Monogram Orthopaedics, Inc. (MGRM)
Automate Your Wheel Strategy on MGRM
With Tiblio's Option Bot, you can configure your own wheel strategy including MGRM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MGRM
- Rev/Share 0.0
- Book/Share 0.332
- PB 7.2597
- Debt/Equity 0.0283
- CurrentRatio 7.004
- ROIC -1.112
- MktCap 86007911.0
- FreeCF/Share -0.2951
- PFCF -8.2781
- PE -5.3006
- Debt/Assets 0.0216
- DivYield 0
- ROE -1.2644
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | MGRM | ROTH MKM | -- | Buy | -- | $4 | Dec. 9, 2024 |
News
Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time
Published: May 06, 2025 by: Accesswire
Sentiment: Neutral
AUSTIN, TX / ACCESS Newswire / May 6, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company revolutionizing orthopedic surgery, will hold a conference call webcast on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time in conjunction with its reported financial results for the first quarter ended March 31, 2025, and to discuss regulatory updates, including its recent FDA 510(k) Clearance for the Monogram mBôsTM TKA System and approval to start clinical trials in India, and key milestones.
Read More
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
Published: April 29, 2025 by: Accesswire
Sentiment: Neutral
Patient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business Days Critical Milestone Achieved for Multi-Center Clinical Trial in India with Strategic Partner Shalby Hospitals for the mBȏs TKA System AUSTIN, TEXAS / ACCESS Newswire / April 29, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company revolutionizing orthopedic surgery, today announced it has obtained regulatory approval from India's Central Drugs Standard Control Organization ("CDSCO") to import its mBôs TKA system to conduct a 102-patient, multi-center clinical investigation evaluating the safety and effectiveness of the Monogram TKA System. The study will …
Read More
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community
Published: March 20, 2025 by: Accesswire
Sentiment: Neutral
AUSTIN, TX / ACCESS Newswire / March 20, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, is pleased to announce its partnership with Urvin, a private, verified message board exclusively for active Monogram shareholders. This platform offers a way for shareholders to communicate directly with each other while providing Monogram with an additional tool to provide important company updates and reach the broadest possible shareholder audience.
Read More
Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India
Published: February 26, 2025 by: Accesswire
Sentiment: Neutral
Company has Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR) Investigator Meeting and Clinical Trial Training Held at the Shalby Hospital in Ahmedabad, India AUSTIN, TX / ACCESS Newswire / February 26, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today provided an update regarding its 510(k) premarket filing submission to the U.S. Food and Drug Administration ("FDA") for the Company's mBôs TKA System. The Company has completed all supplemental testing and submitted …
Read More
About Monogram Orthopaedics, Inc. (MGRM)
- IPO Date 2023-05-18
- Website https://www.monogramorthopedics.com
- Industry Medical - Devices
- CEO Mr. Benjamin Sexson C.F.A.
- Employees 27